11.76
+0.28(+2.44%)
Currency In USD
| Previous Close | 11.48 |
| Open | 11.36 |
| Day High | 11.91 |
| Day Low | 11.28 |
| 52-Week High | 21 |
| 52-Week Low | 7.34 |
| Volume | 984,413 |
| Average Volume | 633,801 |
| Market Cap | 535.6M |
| PE | -73.5 |
| EPS | -0.16 |
| Moving Average 50 Days | 11.86 |
| Moving Average 200 Days | 14.92 |
| Change | 0.28 |
If you invested $1000 in AxoGen, Inc. (AXGN) 10 years ago, it would be worth $3,640.87 as of July 10, 2025 at a share price of $11.76. Whereas If you bought $1000 worth of AxoGen, Inc. (AXGN) shares 5 years ago, it would be worth $1,078.4 as of July 10, 2025 at a share price of $11.76.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Axogen, Inc to Participate at Goldman Sachs Global Healthcare Conference
GlobeNewswire Inc.
May 28, 2025 12:00 PM GMT
ALACHUA, Fla. and TAMPA, Fla., May 28, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Michael Dale, board director,
Axogen Announces Chief Financial Officer Transition
GlobeNewswire Inc.
May 08, 2025 11:00 AM GMT
Lindsey Hartley, CPA, appointed as Chief Financial Officer to succeed Nir NaorALACHUA, Fla. and TAMPA, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for
Axogen, Inc. to report 2025 first quarter financial results on May 8, 2025
GlobeNewswire Inc.
Apr 24, 2025 12:04 PM GMT
ALACHUA and TAMPA, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report 2025 first quarter